Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System(®).

ABSTRACT:

Introduction

Surgical revision rate is a key outcome with all permanent implants. The iFuse Implant System(®) is a permanent implant used to perform minimally invasive sacroiliac joint fusion. The purpose of this study is to determine the surgical revision rate after sacroiliac joint fusion surgery with this system.

Methods

Using two internal sources of information, revision surgeries were identified and linked to index surgeries. The likelihood of revision surgery was calculated using the Kaplan-Meier life table approach. Predictors of revision were explored.

Results

Four-year survivorship free from implant revision was 96.46%. Revision rate did not differ by sex and was lower for age >65. In all, 24% of revisions occurred within the first 30 days after surgery; 63.5

SUBMITTER: Cher DJ 

PROVIDER: S-EPMC4664491 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature